ney transplantation is not available to all patients with ESRD, owing to the paucity of available organs, as well as longstanding racial/ethnic, socioeconomic, sex, age, and geographic disparities in access to kidney transplantation. [3] [4] [5] [6] The traditional framework for examining steps to receiving a kidney transplant in the United States starts with placement on the national deceased donor waiting list (waitlisting), 7 since regional and national surveillance data do not report patient activities prior to waitlisting. However, a focus on earlier steps of the transplantation process, such as referral from a dialysis facility to the transplant center-without which the required medical evaluation, waitlisting, and, ultimately, transplantation cannot occur-may better inform intervention efforts to improve equity in early access to transplantation. 5 Although significant variation in kidney transplantation rates exists across US dialysis facilities, 8 the contribution of heterogeneity in transplant referral by dialysis facility clinicians vs other patient, facility, or neighborhood factors remains unknown.
In the United States, rates of kidney transplantation are the lowest in the Southeast and, in particular, Georgia. 9 Partnering with the community-based Southeastern Kidney Transplant Coalition, which includes ESRD Network 6, patients, transplant centers, social workers, clinicians, patient advocacy groups, and others, we collected kidney transplantation referral data from all Georgia transplant centers as part of our Reducing Disparities in Access to Kidney Transplantation (RaDIANT) Community Study. 10 The purpose of this study is to describe dialysis facility-level referral for kidney transplant evaluation in Georgia and the patient-and facility-level factors associated with referral and access to the national deceased donor waiting list.
Methods

Data Sources
Patient-level data were collected from all transplant referral forms between January 1, 2005, and December 31, 2012, received by all 3 adult transplant centers in Georgia: Emory Transplant Center (Atlanta), Georgia Regents Kidney and Pancreas Transplant Program (Augusta), and Piedmont Transplant Institute (Atlanta). Each transplant center sent referral data securely to ESRD Network 6, which served as the data coordinating center.
To ensure complete patient follow-up and to identify a cohort of nonreferred patients receiving dialysis in Georgia during the same period, we linked referral data to the 2014 United States Renal Data System (USRDS) Standard Analytic Files, which included data on all patients with ESRD from January 1, 2005, through September 20, 2012 . The USRDS is a national surveillance data system that aggregates demographic, diagnosis, treatment, and facility information on nearly 2.5 million patients with ESRD from various data sources, including the Medical Evidence Report (CMS-2728), which is completed for all patients with ESRD at the start of treatment, as well as United Network for Organ Sharing files on waitlisting and transplantation.
Data on characteristics of the patients' residential neighborhoods, as defined by patient 5-digit zip code tabulation area, were obtained from the 2007-2011 American Community Survey (http://www.census.gov/programs-surveys/acs/) and linked by patient zip code at start of dialysis to USRDS. Facility characteristics were obtained from the annual USRDS facility survey data.
This study was approved by the institutional review boards at Emory University, Georgia Regents University, and Piedmont Hospital. Collection of referral data was retrospective, and participant consent was waived.
Study Population
Patients referred to a Georgia transplant center from January 1, 2005, to December 31, 2012, were included in the study. A cohort of both referrals and nonreferrals within the study period was created; first, we identified a cohort of incident patients with ESRD initiating treatment on or after January 1, 2005 , in a Georgia dialysis facility using the USRDS and excluded patients if they were younger than 18 years or 70 years or older or if they were waitlisted prior to starting dialysis. The referral data were then merged with USRDS records. We classified matching patients from the referral data as referred, and the remaining patients in the referral data who were not matched to the incident USRDS cohort of interest were excluded. Patients who started dialysis after September 30, 2011 (to ensure 1 year of follow-up for referral outcomes), were excluded for primary analysis.
Study Variables Outcomes
The primary outcome examined was referral for kidney transplant evaluation to 1 of the 3 transplant centers in Georgia within 1 year of starting dialysis among patients younger than 70 years. Since all dialysis facilities are required to educate patients about transplantation within the first 60 days of starting dialysis, we considered referral within the first year of dialysis as a proxy for access to appropriate care. Referral was defined as the date on which the transplant center received a referral form, primarily from a dialysis facility or referring health professional.
As a secondary outcome, we also examined whether a patient was placed on the national deceased donor waiting list (waitlisted) at any US transplant center within 1 year of referral for transplant evaluation. In addition, we examined crude data on the total number of patients receiving a transplant.
Patient-and Facility-Level Characteristics
Patient characteristics included demographic and clinical data reported by clinicians on the CMS-2728 form at the time of first dialysis treatment, including race/ethnicity, age at incident ESRD, sex, cause of ESRD, as well as other clinical characteristics potentially related to medical eligibility for transplantation, including body mass index greater than 35 (calculated as weight in kilograms divided by height in meters squared), tobacco use, cancer, and comorbidities. Proxies for socioeconomic status included pre-ESRD nephrology care and health insurance at first dialysis treatment, as well as aggregate residential zip code-level data on the percentages of black residents, high school dropouts (residents aged ≥25 years without a high school degree or equivalent), and poor households (living below 100% of the federal poverty threshold).
We assigned each patient to the dialysis facility in which they started treatment, since decisions regarding ESRD treatment are expected to occur within 3 months after starting dialysis for most patients. Facility-level characteristics examined included for-profit status, hospital-based vs freestanding facility, and the ratio of patients to social workers within a facility. We categorized the proportion of patients referred within 1 year over the entire study period at each facility into tertiles and examined whether characteristics varied by tertile.
Statistical Analyses
Demographic and clinical characteristics of the study population were examined using χ 2 or t tests. Because the outcomes were binary and correlated (within facilities), a multivariable generalized linear mixed model was used. An intraclass correlation was es- timated as a measure of proportion of total variance in patient referral attributable to facility-level clustering. Details regarding the multilevel model can be found in the eAppendix in the Supplement. Covariates that were statistically significant in bivariate analyses (P < .05) were included in multilevel analyses. Because the missing pattern was arbitrary, we used a fully conditional specification method to obtain multiple imputed data sets (n = 5) and used likelihood-based methods for inference.
In sensitivity analyses, we considered outcomes of whether patients treated with dialysis were ever referred for kidney transplantation during the entire study period (yes/no) and time to referral (censoring at date of death, waitlisting at any US transplant center, receipt of a living donor transplant, or study end [September 30, 2012)]). SAS version 9.4 (SAS Institute Inc) and Stata version 13.1 (StataCorp) were used for analyses. All P values were 2-sided and considered statistically significant at the P < .05 level.
Results
Study Population
A total of 17 224 patients were referred to Georgia transplant centers over 8 years (January 1, 2005, through December 31, 2012); 15 561 of these (90.3%) were successfully identified and linked to a USRDS patient identifier, 275 of which were duplicates, leaving 15 286 patients with at least 1 referral (Figure 1) . A cohort of 27 605 incident patients with ESRD initiating treatment on or after January 1, 2005, in a Georgia dialysis facility using the USRDS were identified, and patients younger than 18 years (n = 220) or 70 years or older (n = 7856) or who were waitlisted prior to starting dialysis (n = 561) were excluded ( Figure 1 ). Of the 15 286 patients with a first referral, 8391 were identified in USRDS on merging and classified as referred. The remaining 6895 referred patients who were not matched to the incident USRDS cohort of interest were excluded because they were prevalent patients with ESRD (n = 3653 with start dates prior to January 1, 2005), their start date was after September 30, 2012 (n = 23), their dialysis treatment occurred in a facility outside of Georgia (n = 2070) or the location of the dialysis facility was unknown (n = 623), they were younger than 18 years or 70 years or older (n = 71), or they were preemptively waitlisted (n = 455). Last, in the merged data (Figure 1 ), 1675 were excluded because they were referred prior to the start of dialysis; waitlisting and transplantation among these patients, as well as included patients who were referred within a year of dialysis start, referred after 1 year, and never referred are also shown ( Figure 1) .
A total of 15 279 patients at 308 Georgia dialysis facilities were included in primary analyses. Patients excluded because of preemptive referral or preemptive transplantation were more likely young, white, and insured, and had fewer comorbidities, compared with the study population. A more complete description of excluded patients is available in the eAppendix in the Supplement.
Facility Referral and Characteristics
The median within-facility cumulative percentage of patients aged 18 through 69 years referred within 1 year of starting dialysis at 308 Georgia dialysis facilities was 24.4% (interquartile range, 16.7%-33.3%). There were 15 facilities (4.9%) that referred zero patients within 1 year of starting dialysis; the maximum referral in a year was 75.0% ( Figure 2 ). The variance of the facility random effect was significantly different from zero (σ 2 u = 0.35 [SE, 0.04]). After accounting for patient mix, 7.5% of the total variation in referral was explained by facility-level clustering.
The proportions of patients referred within 1 year over the entire study period at each facility were categorized into tertiles (low, 0.0%-19.2%; moderate, 19.3%-31.2%; and high, 31.3%-75.0%). Facilities with the lowest likelihood of referral for transplantion within 1 year of starting dialysis (tertile 3) were more likely to be nonprofit (difference, 17.6% [95% CI, 7.7%-27.4%]), to be hospital-based (vs freestanding; difference, 
Patient Waitlisting and Characteristics
Characteristics of those waitlisted within 1 year of referral vs not are shown in Table 3 . Patients who received a living donor transplant but who were never waitlisted were considered waitlisted (n = 3). Among those referred within 1 year (n = 4280 patients with ESRD), a total of 918 patients (21.5%) were subsequently waitlisted within 1 year of referral.
Factors Associated With Patient Referral for Kidney Transplantation Within 1 Year of Starting Dialysis
In adjusted models (17.6% of patients with imputed covariate data), older age (60-69 vs 18-29 years; odds ratio [OR], b A total of 4 facilities (1.3%) were missing information on BMI and tobacco use; 7 facilities (2.2%) were missing information on pre-ESRD nephrology care; 3 facilities (1.0%) were missing information on primary cause of ESRD; 6 facilities were missing information on for-profit status; and 4 facilities were missing information on hospital-based vs freestanding status.
c Calculated as weight in kilograms divided by height in meters squared. 
Factors Associated With Patient Waitlisting Within 1 Year of Referral
In contrast to referral, sex and age were not significantly associated with waitlisting, and black (vs white) patients had lower odds of waitlisting within 1 year of referral (OR, 0.77 [95% CI, 0.64-0.93]) (Table 4) . Dialysis facility characteristics, including patient to social worker ratio and for-profit status, were not associated with waitlisting.
Transplantation
There were a total of 685 living (36.6%) or deceased (63.4%) donor transplants among the 15 279 individuals (3.1% of all patients with ESRD) during the study follow-up. A total of 467 (10.9%) were among those referred within 1 year of ESRD ( Figure 1 ).
Sensitivity Analyses
Demographic, clinical, socioeconomic, and dialysis facility characteristics were similar among patients who were ever referred for transplantation vs those referred within 1 year (eTable 2 in the Supplement). Hazard ratios from time-to-referral and time-to-waitlisting analyses, which were similar to odds ratios obtained from the main analyses, are shown in eTable 3 and eTable 4 in the Supplement. 
Discussion
We found that only 28.0% of all patients with incident ESRD aged 18 through 69 years in Georgia were referred for transplantation within 1 year of starting dialysis, and referral varied significantly across the 308 dialysis facilities, from 0% to 75.0%. Furthermore, factors associated with lower referral for transplantation, such as white race, older age, and nonprofit facility status, were not necessarily the same as those associated with lower waitlisting. Results of this study suggest that referral for transplantation among Georgia dialysis facilities is not uniform and that national surveillance data measuring waitlisting and transplantation, but not referral, may be inadequate to assess and intervene on disparities in access to kidney transplantation. Although the proportion of patients who should be referred for kidney transplantation within 1 year of ESRD is unknown, 28% is likely low. Ineligibility due to medical contraindications is estimated to be less than 15% in the few singlecenter studies that have been conducted. 11, 12 However, determination of eligibility for transplantation is complex and varies across transplant centers. Although active drug or alcohol abuse, untreated psychiatric conditions, active cancer, systemic infection, and nonadherence are common exclusion criteria for transplant surgery, 13 none are permanent conditions that necessarily preclude transplant referral. National guidelines recommend that, if there is any uncertainty about eligibility, the patient should be referred for transplantation.
14 However, nephrologists and dialysis facility staff may be unsure of which patients to refer, 15 which may lead to significant facility-level variation in referral, as observed in our study. Dialysis professionals may need more guidance about what constitutes an appropriate vs inappropriate referral to ensure that appropriate candidates are referred for transplantation. 16 It is also possible that, despite Centers for
Medicare & Medicaid Services (CMS) requirements that facilities must educate their patients about transplantation and track Nationally, roughly 23% of patients younger than 70 years in a dialysis facility are waitlisted, and 3.4% receive transplants annually. 8 Variation in both waitlisting 20 and transplantation rates 8 among dialysis facilities has been reported even after adjustment for patient factors, with lower transplantation rates among facilities with for-profit status, 8, 21 higher proportions of black patients 8 and patients with limited access to health care, 8, 20 and fewer staff. 8 However, waitlisting and kidney transplantation outcomes among dialysis facilities may not be the ideal quality performance metric for facilities. Lower facility-level transplantation rates may not be attributable to lower waitlisting rates; Ashby et al 22 found that, in general, states with lower waitlisting rates had higher transplantation rates. Many factors beyond the dialysis facility may be associated with placement on the deceased donor waiting list, such as whether the patient started or completed the transplant evaluation, was interested in transplantation, or was medically eligible for transplantation. The need to examine multiple transplant steps is well illustrated by our study, in which we found that factors associated with referral for transplantation were not always the same as those factors associated with waitlisting. For example, we observed racial disparities in waitlisting, as has been reported previously in the United States 5, 23 and in the Southeast 24 and Georgia. 25 Without referral data we might have concluded that observed racial disparities in access to waitlisting were attributable to disparities in referral by a dialysis facility. However, we found that black patients had an OR of 1.22 for referral compared with white patients but an OR of 0.77 for waitlisting. Thus, the reasons for racial disparities in waitlisting may be attributable to racial differences in preferences for kidney transplantation, 26 starting or completing the evaluation, 25 medical eligibility for transplantation, 25, 27 or referral prior to starting dialysis. 28, 29 Patients excluded from our study because of referral or transplantation prior to starting dialysis were more likely white and insured. An examination of all patients with kidney disease may find different results.
In addition, we observed that, as age increased, referral for transplantation decreased-but, among those referred, age was not a significant predictor of waitlisting within a year. This may reflect a difference in the perception of the dialysis facility vs transplant center that older age is a contraindication to transplantation. Consistent with prior literature, 6, 30, 31 for both referral and waitlisting, Medicaid, no access to pre-ESRD nephrology care, and higher neighborhood poverty were associated with reduced access to transplantation. Similarly, several studies have found that for-profit facilities, which may have a financial motivation to keep patients on dialysis, have lower transplantation rates 8, 19, 21 and fewer staff 32 compared with nonprofit facilities. In our study, we found that patients receiving dialysis in for-profit facilities had an OR of 1.51 for referral for transplantation within a year but an equal chance of waitlisting compared with patients in nonprofit facilities. The reasons for this are unclear; it is possible that large, for-profit dialysis chains have responded to the criticism of low transplantation rates by increasing referrals; the reasons for why referrals have not translated into higher waitlisting among patients with ESRD in Georgia should be explored in future research. These findings may have implications for health policy makers, researchers, clinicians, and patients. Low facilitylevel referral for transplantation, as well as the variability in referral across Georgia facilities, suggests that standardized guidelines are needed for the content and duration of a patientclinician educational discussion regarding treatment options at start of dialysis. Socioeconomic status factors were significant barriers to both referral and waitlisting in this study; national policies, such as Medicaid expansion, could help to alleviate disparities. 9, 33 The collection of national transplant referral surveillance data by CMS among all of the more than 5000 US dialysis facilities is needed to identify poorly performing facilities on which to focus quality improvement interventions. A CMS Technical Expert Panel recommended the collection of these data nearly a decade ago, 34 yet there is still no national benchmark for transplant referral in the United States. Researchers should continue to develop, test, and implement pragmatic interventions to improve knowledge of transplantation among both clinicians and patients. In Georgia, such interventions could focus on those dialysis facilities with the lowest proportions of patients with ESRD referred for kidney transplantation. 10 Efforts should not stop at referral; because we found that factors associated with referral and waitlisting may differ, it is important to highlight possible discrepancies between dialysis facilities' perceptions of appropriate referrals and the reality of which patients are actually waitlisted and undergo transplantation in practice. Our study has several strengths, including the collaboration of all transplant centers in Georgia to contribute data for what is to our knowledge the largest regional study of dialysis facility-level referral for kidney transplantation. The use of multilevel modeling techniques and sensitivity analyses ensured the robustness of findings.
However, there are limitations to our study interpretations. Our study was conducted in Georgia, and results may not be generalizable to other states. However, our data emphasize the importance of measuring referral for transplantation to capture its variability both within and between regions. Second, our data source does not capture facility referrals outside of Georgia; however, in a 2012 survey of Georgia dialysis facilities, 10 only 1 facility referred patients to transplant centers exclusively outside of Georgia. We linked referral data to the USRDS registry to capture waitlisting and transplant outcomes at any US transplant center. However, the small number of transplants precluded multivariable and stratified analyses of transplantation as an outcome. While the US-RDS registry includes some patient comorbidities, there are likely many unmeasured and unknown factors that influence a patient's eligibility for transplantation that may vary across dialysis facilities. Although the use of a random-effects model provides estimates of an overall effect while allowing baseline referral to vary at each facility, it is unlikely this approach completely accounts for facility-level variation in patient eligibility. Last, variability in transplant center evaluation could influence the rate of waitlisting and is unaccounted for in our study. Future regional or national studies could examine how transplant center factors influence waitlisting.
Conclusions
In Georgia overall, a limited proportion of patients treated with dialysis were referred for kidney transplant evaluation between 2005 and 2011, but there was substantial variability in referral among facilities. Variables associated with referral were not always associated with waitlisting, suggesting that different factors may account for disparities in referral.
